MYCIO Wealth Partners’s CAPSTONE THERAPEUTICS CORP COM STK (DE) CAPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,200
Closed 827
2016
Q3
$0 Hold
2,200
﹤0.01% 1180
2016
Q2
$0 Hold
2,200
﹤0.01% 1201
2016
Q1
$0 Hold
2,200
﹤0.01% 950
2015
Q4
$0 Hold
2,200
﹤0.01% 952
2015
Q3
$0 Hold
2,200
﹤0.01% 989
2015
Q2
$1K Hold
2,200
﹤0.01% 691
2015
Q1
$0 Hold
2,200
﹤0.01% 724
2014
Q4
$1K Hold
2,200
﹤0.01% 615
2014
Q3
$1K Hold
2,200
﹤0.01% 609
2014
Q2
$1K Hold
2,200
﹤0.01% 619
2014
Q1
$1K Hold
2,200
﹤0.01% 612
2013
Q4
$1K Hold
2,200
﹤0.01% 575
2013
Q3
$1K Hold
2,200
﹤0.01% 523
2013
Q2
$0 Buy
+2,200
New ﹤0.01% 565

MYCIO Wealth Partners's CAPS Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of CAPSTONE THERAPEUTICS CORP COM STK (DE) (CAPS) in Q4 2016, closing a stake of 2,200 shares.

MYCIO Wealth Partners first reported a position in CAPS in Q2 2013 and held it in 14 quarters. The position peaked at $1K in Q2 2015. 0 funds tracked by Wall St. Rank hold CAPS as of Q4 2016.

  • MYCIO Wealth Partners reported no remaining CAPSTONE THERAPEUTICS CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • MYCIO Wealth Partners sold 2,200 CAPSTONE THERAPEUTICS CORP COM STK (DE) shares in Q4 2016.
  • MYCIO Wealth Partners first reported a position in CAPSTONE THERAPEUTICS CORP COM STK (DE) in Q2 2013 and held it in 14 quarters.
  • MYCIO Wealth Partners's CAPSTONE THERAPEUTICS CORP COM STK (DE) position peaked at $1K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held CAPSTONE THERAPEUTICS CORP COM STK (DE) as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.